Cargando…
Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism
Zebrafish (ZF; Danio rerio) larvae have become a popular in vivo model in drug metabolism studies. Here, we investigated the metabolism of methyl 2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (4F-MDMB-BINACA) in ZF larvae after direct administration of the cannabinoid via mic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879502/ https://www.ncbi.nlm.nih.gov/pubmed/35209079 http://dx.doi.org/10.3390/molecules27041290 |
_version_ | 1784658906884079616 |
---|---|
author | Park, Yu Mi Dahlem, Charlotte Meyer, Markus R. Kiemer, Alexandra K. Müller, Rolf Herrmann, Jennifer |
author_facet | Park, Yu Mi Dahlem, Charlotte Meyer, Markus R. Kiemer, Alexandra K. Müller, Rolf Herrmann, Jennifer |
author_sort | Park, Yu Mi |
collection | PubMed |
description | Zebrafish (ZF; Danio rerio) larvae have become a popular in vivo model in drug metabolism studies. Here, we investigated the metabolism of methyl 2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (4F-MDMB-BINACA) in ZF larvae after direct administration of the cannabinoid via microinjection, and we visualized the spatial distributions of the parent compound and its metabolites by mass spectrometry imaging (MSI). Furthermore, using genetically modified ZF larvae, the role of cannabinoid receptor type 1 (CB1) and type 2 (CB2) on drug metabolism was studied. Receptor-deficient ZF mutant larvae were created using morpholino oligonucleotides (MOs), and CB2-deficiency had a critical impact on liver development of ZF larva, leading to a significant reduction of liver size. A similar phenotype was observed when treating wild-type ZF larvae with 4F-MDMB-BINACA. Thus, we reasoned that the cannabinoid-induced impaired liver development might also influence its metabolic function. Studying the metabolism of two synthetic cannabinoids, 4F-MDMB-BINACA and methyl 2-(1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamido)-3,3-dimethylbutanoate (7′N-5F-ADB), revealed important insights into the in vivo metabolism of these compounds and the role of cannabinoid receptor binding. |
format | Online Article Text |
id | pubmed-8879502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88795022022-02-26 Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism Park, Yu Mi Dahlem, Charlotte Meyer, Markus R. Kiemer, Alexandra K. Müller, Rolf Herrmann, Jennifer Molecules Article Zebrafish (ZF; Danio rerio) larvae have become a popular in vivo model in drug metabolism studies. Here, we investigated the metabolism of methyl 2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (4F-MDMB-BINACA) in ZF larvae after direct administration of the cannabinoid via microinjection, and we visualized the spatial distributions of the parent compound and its metabolites by mass spectrometry imaging (MSI). Furthermore, using genetically modified ZF larvae, the role of cannabinoid receptor type 1 (CB1) and type 2 (CB2) on drug metabolism was studied. Receptor-deficient ZF mutant larvae were created using morpholino oligonucleotides (MOs), and CB2-deficiency had a critical impact on liver development of ZF larva, leading to a significant reduction of liver size. A similar phenotype was observed when treating wild-type ZF larvae with 4F-MDMB-BINACA. Thus, we reasoned that the cannabinoid-induced impaired liver development might also influence its metabolic function. Studying the metabolism of two synthetic cannabinoids, 4F-MDMB-BINACA and methyl 2-(1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamido)-3,3-dimethylbutanoate (7′N-5F-ADB), revealed important insights into the in vivo metabolism of these compounds and the role of cannabinoid receptor binding. MDPI 2022-02-15 /pmc/articles/PMC8879502/ /pubmed/35209079 http://dx.doi.org/10.3390/molecules27041290 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Yu Mi Dahlem, Charlotte Meyer, Markus R. Kiemer, Alexandra K. Müller, Rolf Herrmann, Jennifer Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism |
title | Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism |
title_full | Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism |
title_fullStr | Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism |
title_full_unstemmed | Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism |
title_short | Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism |
title_sort | induction of liver size reduction in zebrafish larvae by the emerging synthetic cannabinoid 4f-mdmb-binaca and its impact on drug metabolism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879502/ https://www.ncbi.nlm.nih.gov/pubmed/35209079 http://dx.doi.org/10.3390/molecules27041290 |
work_keys_str_mv | AT parkyumi inductionofliversizereductioninzebrafishlarvaebytheemergingsyntheticcannabinoid4fmdmbbinacaanditsimpactondrugmetabolism AT dahlemcharlotte inductionofliversizereductioninzebrafishlarvaebytheemergingsyntheticcannabinoid4fmdmbbinacaanditsimpactondrugmetabolism AT meyermarkusr inductionofliversizereductioninzebrafishlarvaebytheemergingsyntheticcannabinoid4fmdmbbinacaanditsimpactondrugmetabolism AT kiemeralexandrak inductionofliversizereductioninzebrafishlarvaebytheemergingsyntheticcannabinoid4fmdmbbinacaanditsimpactondrugmetabolism AT mullerrolf inductionofliversizereductioninzebrafishlarvaebytheemergingsyntheticcannabinoid4fmdmbbinacaanditsimpactondrugmetabolism AT herrmannjennifer inductionofliversizereductioninzebrafishlarvaebytheemergingsyntheticcannabinoid4fmdmbbinacaanditsimpactondrugmetabolism |